DE2352662A1 - Verfahren zur herstellung eines uebertragungsfaktors - Google Patents

Verfahren zur herstellung eines uebertragungsfaktors

Info

Publication number
DE2352662A1
DE2352662A1 DE19732352662 DE2352662A DE2352662A1 DE 2352662 A1 DE2352662 A1 DE 2352662A1 DE 19732352662 DE19732352662 DE 19732352662 DE 2352662 A DE2352662 A DE 2352662A DE 2352662 A1 DE2352662 A1 DE 2352662A1
Authority
DE
Germany
Prior art keywords
cells
transfer factor
transfer
factor
lymphocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19732352662
Other languages
German (de)
English (en)
Inventor
Jean-Michel Goust
Robert Louis Moulias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piktor Ltd
Original Assignee
Piktor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piktor Ltd filed Critical Piktor Ltd
Publication of DE2352662A1 publication Critical patent/DE2352662A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19732352662 1972-10-20 1973-10-19 Verfahren zur herstellung eines uebertragungsfaktors Ceased DE2352662A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4848672A GB1443948A (en) 1972-10-20 1972-10-20 Production of immunological material

Publications (1)

Publication Number Publication Date
DE2352662A1 true DE2352662A1 (de) 1974-05-02

Family

ID=10448800

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732352662 Ceased DE2352662A1 (de) 1972-10-20 1973-10-19 Verfahren zur herstellung eines uebertragungsfaktors

Country Status (13)

Country Link
JP (1) JPS4993523A (xx)
AT (1) AT330349B (xx)
BE (1) BE806251A (xx)
CA (1) CA996481A (xx)
CH (1) CH581196A5 (xx)
DE (1) DE2352662A1 (xx)
FR (1) FR2203622B1 (xx)
GB (1) GB1443948A (xx)
IE (1) IE39141B1 (xx)
IL (1) IL43453A (xx)
NL (1) NL7314505A (xx)
SE (1) SE416820B (xx)
ZA (1) ZA738085B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041189A1 (de) * 1980-05-22 1981-12-09 Stiftung Deutsches Krebsforschungszentrum Verfahren zur Herstellung von Interferon II und stimulierte Klone zur Durchführung des Verfahrens

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594097A (en) 1976-12-16 1981-07-30 Int Inst Of Differentiation Production of specific immune nucleic acids cell dialysates and antibodies
GB2156214B (en) * 1982-04-30 1988-05-25 Viragen Inc Topical transfer factor compositions
JPS6028935A (ja) * 1983-07-25 1985-02-14 Hamamatsu Ika Daigaku 新規ヒト抗体産生増強因子およびその製造法
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same
JPS6124520A (ja) * 1984-07-12 1986-02-03 Takeshi Makitsubo 腫瘍壊死因子様物質を抽出する方法
JPS6156131A (ja) * 1984-07-17 1986-03-20 Takeshi Makitsubo 腫瘍壊死因子様物質
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment
RU2624504C1 (ru) * 2015-12-30 2017-07-04 Маргарита Евгеньевна Дмитриева Способ получения трансфер-фактора для профилактики вирусных болезней птиц

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2088229A1 (en) * 1970-05-29 1972-01-07 Anvar Medicaments contg cellular rna - formation of interferon and treatment of viral infections

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041189A1 (de) * 1980-05-22 1981-12-09 Stiftung Deutsches Krebsforschungszentrum Verfahren zur Herstellung von Interferon II und stimulierte Klone zur Durchführung des Verfahrens

Also Published As

Publication number Publication date
ATA887873A (de) 1975-09-15
JPS4993523A (xx) 1974-09-05
AT330349B (de) 1976-06-25
CA996481A (fr) 1976-09-07
IE39141L (en) 1974-04-20
FR2203622B1 (xx) 1977-11-04
AU6166873A (en) 1975-04-24
BE806251A (fr) 1974-02-15
IL43453A (en) 1976-10-31
FR2203622A1 (xx) 1974-05-17
ZA738085B (en) 1974-10-30
SE416820B (sv) 1981-02-09
CH581196A5 (xx) 1976-10-29
GB1443948A (en) 1976-07-28
NL7314505A (xx) 1974-04-23
IE39141B1 (en) 1978-08-16
IL43453A0 (en) 1974-01-14

Similar Documents

Publication Publication Date Title
DE3227262C3 (de) Verfahren zur Herstellung von menschlichem Tumor-Nekrose-Faktor und menschlicher Tumor-Nekrose-Faktor
DE2902136C2 (de) Verfahren zum Herstellen von Interferon
DE3001585A1 (de) Verfahren zur herstellung von interferon typ ii und es enthaltende zubereitungen
EP0584715B1 (de) Verfahren zur Isolierung und Kultivierung von transformierten Zellen sowie Verwendung dieser Zellen zur Herstellung individuumsspezifischer Antikörper
DE2314076C3 (de) Verfahren zur Herstellung von karzinoembyonischem Antigen
DE2717782A1 (de) Verfahren zur gewinnung von insulin mittels genetisch umgebildeter funguszellen
DE2352662A1 (de) Verfahren zur herstellung eines uebertragungsfaktors
DE2043971C3 (de) Antitumorsubstanz aus haemolytischen Streptococcen
DE3325131C2 (xx)
DE1617397A1 (de) Verfahren zur Herstellung eines tumorstatisch wirkenden Mittels
AT395017B (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
DE2420415A1 (de) Eine mitogenische blutfraktion und verfahren zur herstellung derselben
CH650154A5 (de) Wasserloesliche, biologisch aktive fraktion aus dem interzellularen medium des knochenmarks, verfahren zu deren gewinnung und diese enthaltende pharmazeutische zubereitung.
DE2034118A1 (en) Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins
DE3249946C2 (de) hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
DE3913438A1 (de) Verfahren zum herstellen einer immunitaetsgedaechtniszellsuspension
DE3235913C2 (de) Verfahren zur Gewinnung eines Krankheitskontrollprodukts
DE2325196C2 (de) Verfahren zur Herstellung eines eiweißfreien Extraktes aus hämolysiertem Blut
DE397551C (de) Verfahren zur Gewinnung spezifischer Impfstoffe
DE434751C (de) Verfahren zur Herstellung von Antigonorrhoe-Frischvakzinen
EP0889053B1 (de) BK-RiV-Präparate zur Behandlung von proliferativen Zellerkrangungen
DE590908C (de) Verfahren zur Herstellung eines Scharlachserums
DE2719547A1 (de) Immunostimulin, verfahren zu dessen herstellung und seine verwendung zur krebsbekaempfung
AT92081B (de) Verfahren zur Herstellung von avirulenten Heil- und Schutzstoffen für Tuberkulose.
DE2406084A1 (de) Immunodepressives anti-humanlymphozytenserum und verfahren zu dessen herstellung

Legal Events

Date Code Title Description
OGA New person/name/address of the applicant
OD Request for examination
8131 Rejection
8128 New person/name/address of the agent

Representative=s name: HENKEL, G., DR.PHIL. FEILER, L., DR.RER.NAT. HAENZ